Based on trends of prostate cancer mortality in Ghana and the vast majority of patients presenting with high risk disease, it would be advantageous to develop a healthcare policy that will allow for PSA screening along with DRE in a selected cohort of men. Here, KLK3 is linked to prostate carcinoma.